Revised Baxter International Inc Faces Lackluster Performance in Third Quarter 2023 Earnings Season

Baxter International Inc.
Continues Profitability Despite Decline in Sales

DEERFIELD, Ill.
- Baxter International Inc.
(NYSE:BAX), a global leader in medical technology, has reported a successful third quarter of 2023, with the company showcasing its ability to turn a profit despite a decline in sales.
Baxter announced an earnings per share (EPS) of $4.93 during the third quarter, demonstrating a significant improvement compared to the previous quarter.
However, revenue declined by -1.723% to $3.71 billion in proportion to the same quarter of the preceding year.

Despite a decrease in revenue, Baxter International Inc.'s performance outshone that of the rest of the Medical Equipment & Supplies industry, which experienced top-line growth in the third quarter.
Additionally, net profit per share turned positive from $-0.28 per share in the prior quarter, while revenue increased by 0.027% from $3.71 billion.

During the third quarter of the 2023 earnings season, Baxter International Inc.
achieved net profits of $2,511.000 million, a significant improvement from a net loss of $-2,934.000 million during the same quarter last year.
The company's inventories decreased to $2,873.0 million compared to the previous quarter, although this still represents an increase compared to the same period last year.

Looking ahead, Baxter International Inc.
is expected to report its next financial results on February 8, 2024.
Jos (Joe) E.
Almeida, chairman, president, and chief executive officer of Baxter International Inc., expressed confidence in the company's future prospects, stating, Baxter continues to successfully execute upon the slate of strategic actions we announced at the outset of 2023. Almeida emphasized that these initiatives aim to enhance business performance and drive innovation, ultimately creating incremental value for all stakeholders.

Investors may find encouragement in Baxter International Inc.'s recent performance.
Over the past five trading days, the company's shares recorded a solid gain of 5.99%. Furthermore, the shares have seen an impressive increase of 50.59% over the past 12 months.
Currently, Baxter International Inc.
shares trade 9.5% above their 52-week low.

As Baxter International Inc.
navigates the challenging medtech industry, the company's ability to maintain profitability and drive innovation is a positive sign for investors.
With a strong financial position and a focus on strategic actions, Baxter International Inc.
appears poised to overcome market challenges and deliver long-term growth.

Baxter International Inc's Dividend Comparisons

Baxter International Inc's Dividend Pay out

Other BAX's news

Baxter International Inc. Declares Quarterly Cash Dividend of $0.29 per Share of Common Stock, Reinforcing Commitment to Shareholders and Position as a Global Medtech Leader

Baxter International Inc. Declares Quarterly Dividend, Demonstrating Steadfastness in Medtech Leadership

Baxter International Inc Share Price Declines Amidst Acquisition Talks and Mixed Performance

Baxter Internationals Commitment to Global Healthcare and Corporate Responsibility Amid Economic Challenges

Baxter International Inc. Navigating Challenges but Poised for Potential Growth

Baxter International Announces Ambitious New Venture Amidst Revenue Challenges

Baxter International Expands Clinolipid Indication for Pediatric Patients, Records Steady Sales Growth amidst Challenging Market Conditions

Baxter International Inc Sees Income per Share Decline by -22.22% in Q1 of 2024

BAX Reports Surprising Top-line Decline, Initiates Bold Strategies to Bounce Back Strong in Q4 2023

Baxter International Inc.: Revolutionizing Healthcare Waste Management With IV Bag Recycling Program, A Pioneer in Sustainability and Financial Growth

Collaborative Endeavor: Baxter International Foundation and UNICEF Join Hands to Tackle Water Scarcity and Sanitation Crisis in Egypt

Baxter International Inc.: Securing Shareholder Value Through Dividend Growth in the Healthcare Sector

Revised Headline: Baxter International Inc Faces Lackluster Performance in Third Quarter 2023 Earnings Season

The company announced that revenue were lower hardly at all, y/y, amid the financial second quarter of 2023

Lackluster earnings at Baxter International Inc in the January to March 31 2023 time-frame